Detalhe da pesquisa
1.
Clinical Outcomes Before and After Complete Everolimus-Eluting Bioresorbable Scaffold Resorption: Five-Year Follow-Up From the ABSORB III Trial.
Circulation;
140(23): 1895-1903, 2019 12 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31553222
2.
Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.
N Engl J Med;
373(20): 1905-15, 2015 Nov 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26457558
3.
3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III Trial.
J Am Coll Cardiol;
70(23): 2852-2862, 2017 Dec 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29100702